Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Hearing Loss, Sensorineural: early-phase trial registry
11 of 21 indexed Hearing Loss, Sensorineural trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #797 of 28,707 conditions by registered trial count.
21 US clinical trials · 11 currently recruiting · #797 of 28,707 conditions by registered trial count
Hearing Loss, Sensorineural: 21 US clinical trials tracked, 11 recruiting.
Hearing Loss, Sensorineural is the subject of 21 registered US clinical trials on ClinicalTrials.gov, 11 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Frequency Therapeutics, running 2 of these trials.
Enrollment posture brief
Registry condition hearing-loss-sensorineural
OPEN 11 | RECR 52% | LATE 0 | EARLY 2 | RANK #797 | SPON 2
Volume-matched condition peers
Nearest open-share peer: End-Stage Kidney Disease (52% recruiting · 21 trials)
Hearing Loss, Sensorineural lists 11 open slots (52% of 21 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Hearing Loss, Sensorineural on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Hearing Loss, Sensorineural is recruiting above its size-band peers.
11 of 21 indexed trials (52.4%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Hearing Loss, Sensorineural trials is spread across many organizations.
Frequency Therapeutics accounts for 2 of 21 trials (9.5%). 15 distinct sponsors appear on at least one study for this condition label.
-
Most Hearing Loss, Sensorineural trials plan to enrol fewer than 100 people.
Median target enrolment is 50 among the 21 trials that report a genuine target (sentinel values excluded). 16 of those (76.2%) plan for fewer than 100 participants.
-
Hearing Loss, Sensorineural research is mostly interventional.
19 interventional and 2 observational studies make up this index (90.5% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
21 total, page 1 of 1
Preschool Hearing Screening
University of California, San Francisco
NCT06058767
Listening Effort in Cochlear Implant Users
University of Minnesota
NCT06516575
Barriers and Facilitators to OTC Hearing Aids Success
Yu-Hsiang Wu
NCT06499805
Reading Outcomes in Children With Vestibular Loss
Father Flanagan's Boys' Home
NCT05414903
Single-Sided Deafness and Asymmetric Hearing Loss
Med-El Corporation
NCT04506853
Post-Market Clinical Investigation of the IotaSOFT Insertion System
iotaMotion
NCT06664697
MED-EL Remote Care Multi-Center Feasibility Study
Med-El Corporation
NCT05973669
Clinical Utility of Residual Hearing in the Cochlear Implant Ear
Ohio State University
NCT04707885
Self-efficacy-based Auditory Rehabilitation With Over-the-Counter Hearing Aids
University of Arkansas
NCT06560918
Characterizing Variability in Hearing Aid Outcomes in Among Older Adults With Alzheimer's Dementia
Northwestern University
NCT04240561
Evaluation of the Automated Integration of a Robotics and ECochG System for Use With Cochlear Implant Surgery
iotaMotion
NCT06664710
Safety and Effectiveness of Cochlear Implantation in an Expanded Adult Population
Cochlear
NCT06293482
Wide Frequency Band Test of Hearing in Veterans
VA Office of Research and Development
NCT02019888
FX-322 in Adults With Acquired Sensorineural Hearing Loss
Frequency Therapeutics
NCT05086276
Clinical Evaluation of the Cochlear Nucleus CI532 Cochlear Implant in Adults
Cochlear
NCT03007472
Spectral Dynamics and Speech Understanding by Hearing Impaired People
VA Office of Research and Development
NCT01867515
Speech Perception in Bimodal Hearing
Baylor University
NCT05599165
FX-322 in Adults With Severe Sensorineural Hearing Loss
Frequency Therapeutics
NCT04629664
Fitting Strategy Study
Wsaud A/S
NCT04972162
Remote Microphone Candidacy Study
Northwestern University
NCT03897634
Sound Quality Comparisons With Different Hearing Aid Couplings and Venting Systems
Sonova
NCT05180630
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Hearing Loss, Sensorineural records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Hearing Loss, Sensorineural trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Hearing Loss, Sensorineural page
21 registered trials, 11 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 11 Hearing Loss, Sensorineural trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Frequency Therapeutics sponsors the most Hearing Loss, Sensorineural trials on record, review their full trial history before evaluating a specific study. See Frequency Therapeutics's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Hearing Loss, Sensorineural condition card totals 21 registered trials; most-linked intervention FX-322; top US site state Iowa. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.